(08-02-2021, 06:50 PM)Mystic Wanderer Wrote: @"BIAD", no one is coming near me with a big ass cotton wand! I've heard those tests are very dangerous in the wrong hands, and I'd say Soros and Gates can be filed under "the wrong hands".
Me neither!
Not mentioned when the trusty-media told everyone that we'll have three weeks to flatten the curve was...
two jabs just aren't enough.
Quote:BOOSTER BONANZA Pfizer Covid booster vaccines for 32million Brits ‘will start early SeptemberArchived Sun Article:
with 2,000 pharmacies rolling out scheme’
'Pfizer Covid booster jabs will be given to 32million Brits from early September, it has been reported.
Ministers are said to be planning to deliver an average of almost 2.5million third doses a week, with 2,000
pharmacies rolling out the scheme.
Three, the liar's number!
It will mean GPs and other NHS staff can focus their time on patients waiting for other treatments, The Telegraph
reports. All adults over 50, and the immuno-suppressed, will be offered the booster.
And the campaign could start as soon as Sept 6, which, if all goes to plan, would see the rollout finished by early
December. It would mean anyone jabbed at least a fortnight before Christmas would get the benefits from their
third jab in time for the 25th.
Proposals have reportedly been drawn up for the extra Covid vaccine to be co-administered alongside the flu jab,
with one injection in each arm mooted. A government source told The Telegraph: “That is the plan, wherever possible."
But they stressed it “depends on final JCVI [Joint Committee on Vaccination and Immunisation] advice and coronavirus
vaccine booster trials”. It was earlier understood that anyone over 50 who received two doses of the AstraZeneca jab
will get a Pfizer or Moderna booster shot this autumn.
It is to be given with the annual flu jab, as either a new vaccine designed to fight variants or another dose of an existing
shot, reports say. The AstraZeneca vaccine was mainly used on older Brits earlier on in the vaccination programme
-but a source has said that those who first received the Oxford jab "would be getting an mRNA booster."
But the AstraZeneca is not an mRNA vaccine - whereas Pfizer and Moderna are.
This will be the only reason for mixing and matching vaccines, the senior government source told The Times.
A booster jab trial in the UK has shown that people who have already received two doses of AstraZeneca vaccine could
have a stronger immune response if they were given a different jab as a booster.
Karina Butler, the chairwoman of National Immunisation Advisory Committee, told RTE Radio 1’s Today on Wednesday:
“The department is currently considering our advice that has been submitted to them.
"We have made recommendations and we will await the advice.
"In fairness the data that came out on mixing very early on was encouraging but there was very little data on it.
"You have to wait and see.”
A Department of Health and Social Care spokesman said the booster programme would be “informed by the JCVI’s
final advice”, with details of the rollout confirmed “in due course”. An NHS spokesman said: “Community pharmacies
have been an important part of the NHS Covid vaccination programme, the biggest and most successful in the health
service’s history, and they will continue to play a vital role as we move into the next phase this autumn.”
In March it was announced that over-70s will be given a Covid booster jab from September under new government plans.
Vaccines chief Nadhim Zahawi said some people will be given three vaccination doses within the first 10 months of the
jabs being in use.
Those in the top four priority groups for the original rollout – over 70s and frontline NHS and social care workers - will be the
first to get the booster jabs, it's been said.
This comes as the Government continue to incentivise young people to take up their first dose of the vaccine.
But offering young people cut-price fast food if they get jabbed has been branded a panic move by MPs.
The vouchers for vaccine scheme will see companies such as Uber Eats, Deliveroo and Pizza Pilgrims give discounts to
customers who get a vaccine in a push to protect more young Brits.
But the deal flies in the face of the Government’s healthy eating drive. It is aimed at heading off a Tory revolt against Covid
passports for access to nightclubs or football matches.
One senior MP said: “One minute they tell us pizza is bad for us — now they’re handing them out.
"They are in a state of panic.”...'
The scientists say it's because of the delay between the first and the second jab that demands a 'booster',
so what happens from the time after this third injection...? Is that it or is all of this just a different perception
where a type of virulent flu has been used to get the fearful onto the seasonal-jab train?
Quote:Covid-19: Third vaccine dose boosts immune response but may not be needed, say researchersBMJ.com:
The interval between the first and second doses of the Oxford AstraZeneca vaccine can be extended up to 10 months
and a third dose of the vaccine provides a strong boost to the immune response, according to preliminary results.
In a preprint, published on 28 June,1 researchers from the University of Oxford reported that extending the interval between
the first and second dose to 45 weeks resulted in higher antibody titres. They also found that a third dose given 44 to 45
weeks after the second increased antibody titres further, and that adverse events were lower after the second or third dose
than after the first.
Researchers said the results are positive, especially for areas affected by vaccine shortages, as they could provide “greater
flexibility in vaccination schedules.” But they said that currently there is no indication that a booster is needed and stressed
that the “urgent priority” is to ensure people around the world receive their first dose.
The study included volunteers aged 18-55 years from earlier trials of the vaccine—who had received either a single dose or
two doses—who were then invited back for vaccination in March 2021.
Delayed second dose
The researchers found that longer dose intervals between the first and second dose led to higher antibody levels.
They reported that for those who had eight to 12 weeks between dose one and two (median age 39), the median antibody
level 28 days after the second dose was 923 tIgG EU. For those who had a 15 to 25 week interval (median age 36), it was
1860 tIgG EU and for the 44 to 45 week interval (median age 32) it was 3738 tIgG EU.
Six months after the second dose, antibody levels remained significantly higher in the group who had a 15 to 25 week interval
between doses compared with the eight to 12 week interval group—median 1240 tIgG EU and 278 tIgG EU respectively.
The data are not yet available for the 44 to 45 week interval.
The team added that the IgG binding titres to the four variants tested (D614G, alpha, beta, and delta) were “significantly greater”
after the second dose than before the second dose.
Booster dose
For the booster (third) dose, 75 participants who had their first two doses with an interval of eight to 16 weeks were assessed.
The preprint reported that antibody levels 28 days after the third dose were significantly higher than 28 days after the second dose
—3746 tIgG EU and 1792 respectively.
The team also found that binding antibody titres to the beta variant “increased significantly” after the third dose, while neutralising
antibody titres following the booster were higher than those after the second dose against alpha, beta, and delta variants.
In the UK, the government has said it plans to roll out a booster vaccine at the start of this autumn, in order to protect the most
vulnerable ahead of winter.2 But speaking at a Science Media Centre briefing on the preprint, Andrew Pollard, the clinical trials
lead for the vaccine and director of the Oxford Vaccine Group, said, “There’s no indication today that we need boosters.
It is something where we need to keep looking at the data and make decisions as the months go by.
Pollard added, “We have countries facing huge waves of disease at this moment with a largely unvaccinated population.
We saw the new very sharp increase of cases in Bangladesh over the weekend. And that is a situation where getting the first dose
to more people as soon as possible is the most urgent priority. Before third doses are given, we should be trying to make sure all
those vulnerable people—the older adults and those with other health conditions, all around the world—are protected.
That’s the most urgent thing to do.”
Edith Head Gives Good Wardrobe.